Physician profile
Michael Lee Sobel
NPI 1235249301
$490.89
in general payments reported to CMS, 2019-2025
8 companies · $80.74 in 2025
The $80.74 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2023: $56.61 · 2024: $235 · 2025: $80.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $206.15 | 2024-2025 | Purified Cortrophin Gel |
| Medtronic Vascular, INC. | $118.24 | 2019 | |
| Novartis Pharmaceuticals Corporation | $52.62 | 2024-2025 | |
| Glaxosmithkline, LLC. | $43.41 | 2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Inspire Medical Systems, INC. | $22.58 | 2025 | Inspire |
| Vifor Pharma, INC. | $17.98 | 2024 | Veltassa |
| Amgen INC. | $16.71 | 2024 | Tavneos |
| Calliditas Therapeutics US INC. | $13.20 | 2023 | Tarpeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.